Invention Grant
US09458239B2 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)
有权
针对人类抗髓性激素II型受体（AMHR-II）的单克隆抗体及其片段
- Patent Title: Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)
- Patent Title (中): 针对人类抗髓性激素II型受体（AMHR-II）的单克隆抗体及其片段
-
Application No.: US13604200Application Date: 2012-09-05
-
Publication No.: US09458239B2Publication Date: 2016-10-04
- Inventor: Isabelle Teulon , André Pelegrin
- Applicant: Isabelle Teulon , André Pelegrin
- Applicant Address: FR Paris
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
- Current Assignee Address: FR Paris
- Agency: Stites & Harbison, PLLC
- Agent B. Aaron Schulman, Esq.
- Priority: EP06291703 20061102
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; G01N33/53 ; G01N33/50
Abstract:
The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.
Public/Granted literature
Information query
